Search Publications

Publications

Pubmed ID Author Year Title

19704410

Svendsen PF

2009

Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.

19706563

Nur MM

2009

Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome.

19708174

Begum MR

2009

Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome.

19711741

Meczekalski B

2009

[The role of inhibins in functions and dysfunctions of female reproduction--Part II].

19713424

Tosi F

2009

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.

19714502

Crisosto N

2009

Testosterone-induced downregulation of anti-M?llerian hormone expression in granulosa cells from small bovine follicles.

19718565

Liu X

2010

Genetic variants of cyclin-dependent kinase 5 regulatory subunit associated protein 1-like 1 and transcription factor 7-like 2 are not associated with polycystic ovary syndrome in Chinese women.

19718569

Cetinkalp S

2010

The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.

19718570

Unluhizarci K

2010

The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism.

19718584

Alshammari A

2010

Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes?

19720270

Benjamins LJ

2009

Evaluation and management of polycystic ovary syndrome.

19721481

Carlsen SM

2009

[Use of metformin in polycystic ovary syndrome].

19723303

Mohamed-Hussein ZA

2009

Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data.

19726039

Pall M

2010

The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

19729161

Ashrafinia M

2009

Comparison of metformin treatment and laparoscopic ovarian diathermy in patients with polycystic ovary syndrome.

19729414

Bausenwein J

2010

Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women.

19729797

Samy N

2009

Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.

19732872

Farhi J

2010

Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome.

19732886

Gu BH

2009

Follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome.

19732888

Abu Hashim H

2010

Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial.

19733099

Shah B

2010

Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome.

19734445

Fauser BC

2009

Predicting pregnancy in women with polycystic ovary syndrome.

19735349

Jeanes YM

2009

Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians.

19740916

Gowri V

2009

Investigating infertility.

19744034

Erdogan M

2009

The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.

19749195

James WH

2009

A new method for testing a hypothesis on a cause of polycystic ovary syndrome.

19749677

De Leo V

2009

[Low dose oral contraceptives: 30 microg are still used?].

19754381

Motta AB

2009

Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome.

19757237

Duijkers IJ

2010

Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women.

19757275

Qublan HS

2009

Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial.

19761360

Overbeek A

2009

Pharmacogenomics of ovulation induction: facilitating decisions on who, when and how to treat.

19763092

Oh JY

2010

Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome.

19765700

Rocha MP

2010

Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.

19766209

Hu Z

2010

The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome.

19771438

Verit FF

2010

High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.

19775306

Seneviratne HR

2009

Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome.

19778476

Dittrich R

2009

Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.

19778486

Chittenden BG

2009

Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review.

19781047

Zhang HY

2009

Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.

19781696

Harris-Glocker M

2010

Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.

19782347

Verit FF

2009

Serologic markers of autoimmunity in women with the polycystic ovary syndrome.

19782351

Wang Y

2010

Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant.

19782356

Kaya C

2010

Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome.

19782423

Kawai T

2009

Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.

19782978

Ozerkan K

2010

Insulin-like growth factor-1 and insulin-like growth factor-binding protein-1 in patients with polycystic ovary syndrome during clomiphene citrate therapy.

19794294

Meczekalski B

2009

Oocyte-specific genes: role in fertility and infertility.

19796964

de Zegher F

2009

Adipose tissue expandability and the early origins of PCOS.

19800728

Papaleo E

2009

Contribution of myo-inositol to reproduction.

19803824

Wiegratz I

2006

Extended and continuous use of hormonal contraceptives to reduce menstruation.

19803867

Lim SS

2007

Obesity management in women with polycystic ovary syndrome.

19803884

Unluhizarci K

2005

The evaluation and treatment of hirsute women.

19803963

Diamanti-Kandarakis E

2006

Update on polycystic ovary syndrome.

19803983

Szalat A

2007

Gender-specific care of diabetes.

19803994

Yasmin E

2007

Management of polycystic ovary syndrome.

19804008

Seng SW

2006

Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation.

19804310

Rizzo M

2007

Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention.

19805079

Mutskov V

2009

The human insulin gene is part of a large open chromatin domain specific for human islets.

19808859

de Zegher F

2009

Early Origins of polycystic ovary syndrome: hypotheses may change without notice.

19809318

Palomba S

2009

Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.

19809879

Ode KL

2009

Identification and treatment of metabolic complications in pediatric obesity.

19811070

Atiomo WU

2009

Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome.

19811236

Carmina E

2009

Cardiovascular risk and events in polycystic ovary syndrome.

19815190

Gosman GG

2010

Reproductive health of women electing bariatric surgery.

19818376

Racho? D

2010

Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.

19820292

Misiti S

2010

Proteomic profiles in hyperandrogenic syndromes.

19820295

Selimoglu H

2010

The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.

19821101

Chu Y

2009

The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance.

19821295

Brown J

2009

Clomiphene and anti-oestrogens for ovulation induction in PCOS.

19821299

Tang T

2009

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

19827418

Klein F

2009

[Polycystic ovary syndrome. Diet helps control hormone chaos].

19827632

Reznikov OH

2009

[Enhancing effect of androgen receptor antagonist on gonadotropic inductors of ovulation in rats with polycystic ovaries].

19828691

Zhu JQ

2010

Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.

19832825

Dewailly D

2010

Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level.

19832931

Caruso S

2009

Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.

19834313

Moran LJ

2010

Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

19835809

Fambrini M

2009

Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report.

19837913

Coviello AD

2009

High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.

19837928

Jones MR

2009

Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.

19838579

Fernandes JB

2009

[Obesity and altered arterial structure in young women with micropolycystic ovary syndrome].

19841045

Diamanti-Kandarakis E

2010

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.

19843067

Nakhjavani M

2009

Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism.

19843375

Oyawoye OA

2009

The interaction between follicular fluid total antioxidant capacity, infertility and early reproductive outcomes during in vitro fertilization.

19844814

Wang J

2009

FABP4: a novel candidate gene for polycystic ovary syndrome.

19845194

Awonuga AO

2009

Non-adherence to instructions to cancel a cycle in a patient overstimulated with gonadotropins in a planned intrauterine insemination cycle.

19845195

Chervenak FA

2009

Preventive ethics and subsequent care of patients self-administering ovarian stimulation for the management of infertility.

19846740

Alsamarai S

2009

Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

19848208

Li Q

2009

[Effect of bushen tongmai recipe on insulin resistance and ovulation dysfunction in PCOS rats accompanied with insulin resistance].

19850592

Rosencrantz MA

2010

Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.

19852285

Yu J

2009

[Fifty years of experience on integrative medical treatment of polycystic ovarian syndrome].

19852286

Huang HF

2009

[Genetic mechanism of polycystic ovarian syndrome].

19852287

Wu XK

2009

[Exploration into the pathogenesis and treatment of polycystic ovarian syndrome from viewpoints of menstrual disorder and phlegm accumulation in uterus].

19852289

Zhao H

2009

[Advantages of Chinese medicine for treatment of blood sugar and lipid metabolic disorders in patients with polycystic ovarian syndrome].

19852296

Gao L

2009

[Of berberine and puerarin on dexamethasone-induced insulin resistance in porcine ovarian thecal cells].

19855107

Lujan ME

2010

Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.

19856137

Lin S

2009

The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.

19859840

Yan Q

2009

Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women.

19860350

Check JH

2009

Failure to have menses following progesterone withdrawal in a normal estrogenic woman with polycystic ovarian syndrome who menstruates with oral contraceptives.

19874358

Ingram JR

2010

Management of acne vulgaris: an evidence-based update.

19883437

Yamada S

2009

Stromal luteoma and nodular hyperthecosis of the bilateral ovaries associated with atypical endometrial hyperplasia of the uterus.

19883744

Manner?s L

2010

Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome.